Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis

Ther Apher Dial. 2009 Jun;13(3):238-9. doi: 10.1111/j.1744-9987.2009.00694.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Half-Life
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacokinetics*
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Pioglitazone
  • Renal Dialysis*
  • Thiazolidinediones / administration & dosage
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / pharmacokinetics*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Pioglitazone